Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76776 - 76800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tamoxifen	Approved Investigational	FABP1	2168	upregulated	Tamoxifen results in increased expression of FABP1 mRNA	2p11.2	A20438 A20646
Tamoxifen	Approved Investigational	FASLG	356	downregulated	Tamoxifen results in decreased expression of FASLG mRNA	1q24.3	A22735
Tamoxifen	Approved Investigational	FASLG	356	upregulated	[Tamoxifen results in increased expression of TGFB1 protein] which results in increased expression of FASLG mRNA	1q24.3	A22735
Tamoxifen	Approved Investigational	FICD	11153	upregulated	Tamoxifen results in increased expression of FICD mRNA	12q23.3	A24383
Tamoxifen	Approved Investigational	FNDC4	64838	upregulated	Tamoxifen results in increased expression of FNDC4 mRNA	2p23.3	A20438 A20430
Tamoxifen	Approved Investigational	FOS	2353	upregulated	Tamoxifen results in increased expression of FOS mRNA	14q24.3	A21264
Tamoxifen	Approved Investigational	FOXA1	3169	downregulated	Tamoxifen results in decreased expression of FOXA1 mRNA	14q21.1	A20645
Tamoxifen	Approved Investigational	FOXM1	2305	downregulated	Tamoxifen results in decreased expression of FOXM1 mRNA	12p13.33	A21288
Tamoxifen	Approved Investigational	FOXN3	1112	upregulated	Tamoxifen results in increased expression of FOXN3 mRNA	14q31.3-q32.11	A21115
Tamoxifen	Approved Investigational	FOXP3	50943	upregulated	Tamoxifen results in increased expression of FOXP3 mRNA	Xp11.23	A22735
Tamoxifen	Approved Investigational	FST	10468	downregulated	Tamoxifen results in decreased expression of FST mRNA	5q11.2	A21168
Tamoxifen	Approved Investigational	FUS	2521	downregulated	Tamoxifen results in decreased expression of FUS mRNA	16p11.2	A21116
Tamoxifen	Approved Investigational	GADD45A	1647	upregulated	Tamoxifen results in increased expression of GADD45A mRNA	1p31.3	A3616 A24385
Tamoxifen	Approved Investigational	GAL	51083	downregulated	Tamoxifen results in decreased expression of GAL mRNA	11q13.2	A24383
Tamoxifen	Approved Investigational	GAS6	2621	upregulated	Tamoxifen results in increased expression of GAS6 mRNA	13q34	A21112
Tamoxifen	Approved Investigational	GDPD3	79153	upregulated	Tamoxifen results in increased expression of GDPD3 mRNA	16p11.2	A20438 A20430 A20646
Tamoxifen	Approved Investigational	GFPT1	2673	upregulated	Tamoxifen results in increased expression of GFPT1 mRNA	2p13.3	A3616
Tamoxifen	Approved Investigational	GNB4	59345	upregulated	Tamoxifen results in increased expression of GNB4 mRNA	3q26.33	A21112
Tamoxifen	Approved Investigational	GPSM2	29899	upregulated	Tamoxifen results in increased expression of GPSM2 mRNA	1p13.3	A24383
Tamoxifen	Approved Investigational	GYPE	2996	downregulated	Tamoxifen results in decreased expression of GYPE mRNA	4q31.21	A24383
Tamoxifen	Approved Investigational	GZMB	3002	downregulated	Tamoxifen results in decreased expression of GZMB mRNA	14q12	A22735
Tamoxifen	Approved Investigational	GZMB	3002	upregulated	[Tamoxifen results in increased expression of TGFB1 protein] which results in increased expression of GZMB mRNA	14q12	A22735
Tamoxifen	Approved Investigational	H19	283120	upregulated	Tamoxifen results in increased expression of H19 mRNA	11p15.5	A21164
Tamoxifen	Approved Investigational	H2AFZ	3015	downregulated	Tamoxifen results in decreased expression of H2AFZ mRNA	4q23	A22732
Tamoxifen	Approved Investigational	HCRTR2	3062	downregulated	Tamoxifen results in decreased expression of HCRTR2 mRNA	6p12.1	A24383

Displaying entries 76776 - 76800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability